Biohaven Pharmaceutical Hld

PTC Therapeutics

Intra-Cellular Therapies

Xenon Pharmaceuticals

Catalyst Pharmaceuticals

Alkermes

ACADIA Pharma

Neurocrine Biosciences

Axonics ModulationTechnologies Inc

Edgewise Therapeutics

iShares Neuroscience And Healthcare ETF

IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.

Simplify Tail Risk Strategy ETF

VanEck Vectors Gold Miners ETF

VanEck Junior Gold Miners ETF

U.S. Global GO GOLD and Precious Metal Miners ETF

Simplify Interest Rate Hedge ETF

Sprott Gold Miners ETF

Global X Silver Miners ETF

Amplify Junior Silver Miners ETF

iShares MSCI Global Silver Miners ETF

These were the best-performing ETFs for the week ending Sept. 30, 2022. NOTE: We've excluded funds that use leverage or make inverse bets on their underlying assets.

These 10 ETFs Were Last Week's Top Performers: Oct 3, 2022

Virtus LifeSci Biotech Clinical Trials ETF

SoFi Web 3 ETF

Invesco DB US Dollar Index Bullish Fund

Wall Street was downbeat last week led by Apple after it dropped plans to boost production of its new iPhones.

4 Best ETF Areas of Last Week That Are Up At Least 5%

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

ProShares Ultra Nasdaq Biotechnology

First Trust NYSE Arca Biotechnology Index Fund

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

iShares Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

Invesco Dynamic Biotechnology & Genome ETF

SPDR S&P Biotech ETF

Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.

Why Now Could Be The Time To Consider Neuroscience Investments

BlackRock has launched the iShares Neuroscience and Healthcare ETF (IBRN), enhancing its lineup of thematic ETFs available to investors. The new fund, listed on the NYSE on August 26, is the first ETF focused on neuroscience and the growth and innovation related to the treatment of neurological diseases.

BlackRock Adds New ETF to iShares Thematic Lineup

News for iShares Neuroscience And Healthcare ETF ETF (IBRN)